Nov 07, 2018
Myovant Strengthens Management Team and Adds New Directors to the Board
May 18, 2018
Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange
May 17, 2018
Amneal Announces FDA Approval and Launch of Generic Welchol® (Colesevelam HCl) Tablets, 625 mg
May 15, 2018
Amneal Introduces First Generic for Mephyton® (Phytonadione) Tablets, 5mg
May 11, 2018
Amneal Announces Actions to Streamline Operations and Capture Cost Synergies
May 07, 2018
Amneal and Impax Complete Business Combination
May 07, 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
May 07, 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
May 02, 2018
Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP
Apr 30, 2018
$20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®
Apr 27, 2018
Amneal And Impax Receive FTC Clearance For Business Combination
Apr 27, 2018
ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax
Mar 29, 2018
Technical Perspectives on Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer
Mar 27, 2018
Impax Shareholders Approve Proposed Business Combination with Amneal
Mar 23, 2018
Lannett Strengthens, Augments Management Team
Mar 14, 2018
Amneal Gains Approval for Erythromycin Tablets USP
Mar 07, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference
Mar 01, 2018
Amneal Launches Generic for Tamiflu® Oral Suspension
Mar 01, 2018
Impax Reports Fourth Quarter and Full Year 2017 Results
Feb 20, 2018
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets